|
Stable Angina |
|
Medical Therapies |
|  PCI Versus Medical Management |
AVERT: Atorvastatin Versus Revascularization Treatments Trial
-Trial Overview by Dr. Bertram Pitt (AHA 1998)
COURAGE: Clinical Outcomes Utilizing Revascularization And Aggressive Guideline-Driven Drug Evaluation
-Outcomes by Dr. William E. Boden
-Angioplasty: A Reality Check! What Does Evidence Based Medicine Tell Us? by Dr. Duane S. Pinto
PCI vs Conservative Therapy for Chronic CAD
-Results from Meta-Analysis 2005 by Dr. Demosthenes G. Katritsis and Dr. John P.A. Ioannidis
Survival PCI vs Medical Management: Comparison of the Short-Term Survival Benefit Associated with Revascularization Compared with Medical Therapy in Patients with No Prior Coronary Artery Disease Undergoing Stress Myocardial Perfusion Single Photon Emission Computed Tomography
-Study Overview by Dr. Rory Hachamovitch et al (2003)
Toxicity and Screening Recommendations for Amiodarone Use
|  Medical Therapies |
ACT34-CMI: Study of Intramyocardial CD34+ Cell Therapy for Refractory Angina
-Study Overview by Dr. Douglas W. Losordo
AGENT 3: Angiogenic Gene Therapy - 3
-A Multicenter, Prospective, Randomized Trial of Intracoronary Administration of Ad5FGF-4 in Patients With No Revascularization Options by Dr. Timothy Henry (ACC 2005)
ERICA: The Efficacy of Ranolazine in Chronic Angina
-Trial Overview by Dr. Peter H. Stone et al
MUST-EECP: Multicenter Study of Enhanced External Counterpulsation
-EECP Reduces Time to ST-Segment Depression and Episodes of Angina with Improved Long-Term Quality of Life by Vasotec Inc.
Who Are We? Slide Downloading Policy Financial Disclosure We Do Not Promote Off Label Product Use Copyright Source of Slides Editorial Policy Links Policy Privacy Policy Access CME Programs
© 1999-2009 by Clinical Trial Results .org. None of the materials on this website may be reproduced, modified, distributed, transmitted, republished, displayed, or performed unless prior written approval is obtained by Clinical Trial Results. All such requests should be forwarded to Susan J. Marble at smarble@clinicaltrialresults.org. For further information please see the Policy section. Webmaster